117 related articles for article (PubMed ID: 27677272)
1. A Review of Outcomes for Colorectal Adenomas.
Vollmer RT
Am J Clin Pathol; 2016 Nov; 146(5):567-571. PubMed ID: 27677272
[TBL] [Abstract][Full Text] [Related]
2. Genomic instability and oncogene amplifications in colorectal adenomas predict recurrence and synchronous carcinoma.
Habermann JK; Brucker CA; Freitag-Wolf S; Heselmeyer-Haddad K; Krüger S; Barenboim L; Downing T; Bruch HP; Auer G; Roblick UJ; Ried T
Mod Pathol; 2011 Apr; 24(4):542-55. PubMed ID: 21102417
[TBL] [Abstract][Full Text] [Related]
3. Villous component as a marker for synchronous and metachronous colorectal adenomas.
Miura S; Shikata J; Hosoda Y
Dis Colon Rectum; 1992 Dec; 35(12):1148-53. PubMed ID: 1473416
[TBL] [Abstract][Full Text] [Related]
4. Complication and local recurrence rate after endoscopic resection of large high-risk colorectal adenomas of ≥3 cm in size.
Seidel J; Färber E; Baumbach R; Cordruwisch W; Böhmler U; Feyerabend B; Faiss S
Int J Colorectal Dis; 2016 Mar; 31(3):603-11. PubMed ID: 26754070
[TBL] [Abstract][Full Text] [Related]
5. Prognostic model for patients treated for colorectal adenomas with regard to development of recurrent adenomas and carcinoma.
Jensen P; Krogsgaard MR; Christiansen J
Eur J Surg; 1996 Mar; 162(3):229-34; discussion 235. PubMed ID: 8695739
[TBL] [Abstract][Full Text] [Related]
6. Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability.
Hermsen M; Postma C; Baak J; Weiss M; Rapallo A; Sciutto A; Roemen G; Arends JW; Williams R; Giaretti W; De Goeij A; Meijer G
Gastroenterology; 2002 Oct; 123(4):1109-19. PubMed ID: 12360473
[TBL] [Abstract][Full Text] [Related]
7. Clinico-pathological aspects of colorectal serrated adenomas.
Chandra A; Sheikh AA; Cerar A; Talbot IC
World J Gastroenterol; 2006 May; 12(17):2770-2. PubMed ID: 16718767
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis.
Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK
Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157
[TBL] [Abstract][Full Text] [Related]
9. MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas.
Farchoukh L; Kuan SF; Dudley B; Brand R; Nikiforova M; Pai RK
Am J Surg Pathol; 2016 Oct; 40(10):1390-9. PubMed ID: 27438990
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of PCNA and CD34 in colorectal adenomas and carcinomas using specified automated cellular image analysis system: a clinicopathologic study.
Qasim BJ; Ali HH; Hussein AG
Saudi J Gastroenterol; 2012; 18(4):268-76. PubMed ID: 22824771
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of endoscopic treatment of second recurrences of large nonpedunculated colorectal adenomas.
Kim HG; Sethi S; Banerjee S; Friedland S
Surg Endosc; 2016 Jun; 30(6):2457-64. PubMed ID: 26423413
[TBL] [Abstract][Full Text] [Related]
12. Natural history and long-term outcomes of patients treated for early stage colorectal cancer.
Freeman HJ
Can J Gastroenterol; 2013 Jul; 27(7):409-13. PubMed ID: 23862173
[TBL] [Abstract][Full Text] [Related]
13. Management of sporadic duodenal adenomas and the association with colorectal neoplasms: a retrospective cohort study.
van Heumen BW; Mul K; Nagtegaal ID; van Kouwen MC; Nagengast FM
J Clin Gastroenterol; 2012; 46(5):390-6. PubMed ID: 22178960
[TBL] [Abstract][Full Text] [Related]
14. CD44v6 down-regulation is an independent prognostic factor for poor outcome of colorectal carcinoma.
Wang L; Liu Q; Lin D; Lai M
Int J Clin Exp Pathol; 2015; 8(11):14283-93. PubMed ID: 26823744
[TBL] [Abstract][Full Text] [Related]
15. Dynamic down-regulation of Krüppel-like factor 4 in colorectal adenoma-carcinoma sequence.
Xu J; Lü B; Xu F; Gu H; Fang Y; Huang Q; Lai M
J Cancer Res Clin Oncol; 2008 Aug; 134(8):891-8. PubMed ID: 18264726
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression.
Komor MA; de Wit M; van den Berg J; Martens de Kemp SR; Delis-van Diemen PM; Bolijn AS; Tijssen M; Schelfhorst T; Piersma SR; Chiasserini D; Sanders J; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; Carvalho B; Meijer GA; Jimenez CR; Fijneman RJA;
Int J Cancer; 2020 Apr; 146(7):1979-1992. PubMed ID: 31411736
[TBL] [Abstract][Full Text] [Related]
17. Evidence for accelerated colorectal adenoma--carcinoma progression in MUTYH-associated polyposis?
Nieuwenhuis MH; Vogt S; Jones N; Nielsen M; Hes FJ; Sampson JR; Aretz S; Vasen HF
Gut; 2012 May; 61(5):734-8. PubMed ID: 21846783
[TBL] [Abstract][Full Text] [Related]
18. The natural history of adenomas.
Risio M
Best Pract Res Clin Gastroenterol; 2010 Jun; 24(3):271-80. PubMed ID: 20510828
[TBL] [Abstract][Full Text] [Related]
19. Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression.
de Wit M; Carvalho B; Delis-van Diemen PM; van Alphen C; Beliën JAM; Meijer GA; Fijneman RJA
PLoS One; 2017; 12(5):e0174768. PubMed ID: 28481899
[TBL] [Abstract][Full Text] [Related]
20. Risk related surveillance following colorectal polypectomy.
Nusko G; Mansmann U; Kirchner T; Hahn EG
Gut; 2002 Sep; 51(3):424-8. PubMed ID: 12171968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
